Phosphorylated Syk expression is enhanced in Nasu-Hakola disease brains

Neuropathology

Volumn 32, Issue 2, 2012, Pages 149-157

  Satoh, Jun Ichi ^a   Tabunoki, Hiroko ^a   Ishida, Tsuyoshi ^d   Yagishita, Saburo ^e   Jinnai, Kenji ^f   Futamura, Naonobu ^f   Kobayashi, Michio ^g   Toyoshima, Itaru ^h   Yoshioka, Toshiaki ^h   Enomoto, Katsuhiko ^h   Arai, Nobutaka ^b   Saito, Yuko ^c   Arima, Kunimasa ^c  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^d 1 7 1 Kohnodai   (Japan)

^e KANAGAWA REHABILITATION CENTER   (Japan)

^f Japan   (Japan)

^g National Hospital Organization Akita National Hospital Yurihonjo   (Japan)

^h AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

KeyMolnet; Nasu Hakola disease; Phosphorylation; Src; Syk

Indexed keywords

BRAIN PROTEIN; DNAX ACTIVATION PROTEIN 12; PROTEIN KINASE SYK; PROTEIN TYROSINE KINASE; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY SPECIFICITY; ARTICLE; ASTROCYTE; AUTOPSY; AUTOSOMAL RECESSIVE DISORDER; BONE CYST; BRAIN CORTEX; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; FEMALE; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MACROPHAGE; MALE; MEMBRANOUS LIPODYSTROPHY; MICROGLIA; NERVE CELL; NERVE DEGENERATION; OLIGODENDROGLIA; PRESENILE DEMENTIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADULT; AGED; BRAIN; CEREBRAL CORTEX; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HIPPOCAMPUS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPODYSTROPHY; MALE; MIDDLE AGED; OSTEOCHONDRODYSPLASIAS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; SUBACUTE SCLEROSING PANENCEPHALITIS; UP-REGULATION;

EID: 84858999368     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2011.01256.x     Document Type: Article

References (35)

1. Nasu T, Tsukahara Y, Terayama K. A lipid metabolic disease -"Membranous lipodystrophy"- an autopsy case demonstrating numerous peculiar membrane-structures composed of compound lipid in bone and bone marrow and various adipose tissues. Acta Pathol Jpn 1973; 23: 539-558.
2. Hakola HP. Neuropsychiatric and genetic aspects of a new hereditary disease characterized by progressive dementia and lipomembranous polycystic osteodysplasia. Acta Psychiatr Scand Suppl 1972; 232: 1-173.
3. Bianchin MM, Capella HM, Chaves DL etal. Nasu-Hakola disease (polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy - PLOSL): a dementia associated with bone cystic lesions. From clinical to genetic and molecular aspects. Cell Mol Neurobiol 2004; 24: 1-24.
4. Tanaka J. Nasu-Hakola disease: a review of its leukoencephalopathic and membranolipodystrophic features. Neuropathology 2000; 20: S25-S29.
5. Paloneva J, Manninen T, Christman G etal. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am J Hum Genet 2002; 71: 656-662.
6. Klünemann HH, Ridha BH, Magy L etal. The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2. Neurology 2005; 64: 1502-1507.
7. Ivashkiv LB. Cross-regulation of signaling by ITAM-associated receptors. Nat Immunol 2009; 10: 340-347.
8. Lanier LL. DAP10- and DAP12-associated receptors in innate immunity. Immunol Rev 2009; 227: 150-160.
9. Sada K, Takano T, Yanagi S, Yamamura H. Structure and function of Syk protein-tyrosine kinase. J Biochem 2001; 130: 177-186.
10. Mócsai A, Ruland J, Tybulewicz VL. The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat Rev Immunol 2010; 10: 387-402.
11. Kaifu T, Nakahara J, Inui M etal. Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J Clin Invest 2003; 111: 323-332.
12. Roumier A, Béchade C, Poncer JC etal. Impaired synaptic function in the microglial KARAP/DAP12-deficient mouse. J Neurosci 2004; 24: 11421-11428.
13. Nataf S, Anginot A, Vuaillat C etal. Brain and bone damage in KARAP/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages. Am J Pathol 2005; 166: 275-286.
14. Otero K, Turnbull IR, Poliani PL etal. Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and beta-catenin. Nat Immunol 2009; 10: 734-743.
15. Takahashi K, Rochford CD, Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med 2005; 201: 647-657.
16. Satoh JI, Tabunoki H, Ishida T etal. Immunohistochemical characterization of microglia in Nasu-Hakola disease brains. Neuropathology 2011; 31: 363-375.
17. Zhang J, Billingsley ML, Kincaid RL, Siraganian RP. Phosphorylation of Syk activation loop tyrosines is essential for Syk function. An in vivo study using a specific anti-Syk activation loop phosphotyrosine antibody. J Biol Chem 2000; 275: 35442-35447.
18. Mócsai A, Humphrey MB, Van Ziffle JA etal. The immunomodulatory adapter proteins DAP12 and Fc receptor γ-chain (FcRγ) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc Natl Acad Sci U S A 2004; 101: 6158-6163.
19. Hamerman JA, Ni M, Killebrew JR, Chu CL, Lowell CA. The expanding roles of ITAM adapters FcRγ and DAP12 in myeloid cells. Immunol Rev 2009; 232: 42-58.
20. Park H, Cox D. Syk regulates multiple signaling pathways leading to CX3CL1 chemotaxis in macrophages. J Biol Chem 2011; 286: 14762-14769.
21. Zhou F, Hu J, Ma H, Harrison ML, Geahlen RL. Nucleocytoplasmic trafficking of the Syk protein tyrosine kinase. Mol Cell Biol 2006; 26: 3478-3491.
22. Satoh J, Tabunoki H, Arima K. Molecular network analysis suggests aberrant CREB-mediated gene regulation in the Alzheimer disease hippocampus. Dis Markers 2009; 27: 239-252.
23. Yanagi S, Inatome R, Takano T, Yamamura H. Syk expression and novel function in a wide variety of tissues. Biochem Biophys Res Commun 2001; 288: 495-498.
24. Tsujimura T, Yanagi S, Inatome R etal. Syk protein-tyrosine kinase is involved in neuron-like differentiation of embryonal carcinoma P19 cells. FEBS Lett 2001; 489: 129-133.
25. Hatterer E, Benon A, Chounlamountri N etal. Syk kinase is phosphorylated in specific areas of the developing nervous system. Neurosci Res 2011; 70: 172-182.
26. Negro A, Brunati AM, Donella-Deana A, Massimino ML, Pinna LA. Multiple phosphorylation of α-synuclein by protein tyrosine kinase Syk prevents eosin-induced aggregation. Faseb J 2002; 16: 210-212.
27. Lebouvier T, Scales TM, Hanger DP etal. The microtubule-associated protein tau is phosphorylated by Syk. Biochim Biophys Acta 2008; 1783: 188-192.
28. Hirose M, Kitano J, Nakajima Y etal. Phosphorylation and recruitment of Syk by immunoreceptor tyrosine-based activation motif-based phosphorylation of tamalin. J Biol Chem 2004; 279: 32308-32315.
29. Kerrigan AM, Brown GD. Syk-coupled C-type lectin receptors that mediate cellular activation via single tyrosine based activation motifs. Immunol Rev 2010; 234: 335-352.
30. Shefler I, Sagi-Eisenberg R. Gi-mediated activation of the Syk kinase by the receptor mimetic basic secretagogues of mast cells: role in mediating arachidonic acid/metabolites release. J Immunol 2001; 167: 475-481.
31. Takano T, Sada K, Yamamura H. Role of protein-tyrosine kinase syk in oxidative stress signaling in B cells. Antioxid Redox Signal 2002; 4: 533-541.
32. Gao J, Zoller KE, Ginsberg MH, Brugge JS, Shattil SJ. Regulation of the pp72syk protein tyrosine kinase by platelet integrin αIIbβ3. EMBO J 1997; 16: 6414-6425.
33. Tsang E, Giannetti AM, Shaw D etal. Molecular mechanism of the Syk activation switch. J Biol Chem 2008; 283: 32650-32659.
34. Rao N, Ghosh AK, Ota S etal. The non-receptor tyrosine kinase Syk is a target of Cbl-mediated ubiquitylation upon B-cell receptor stimulation. EMBO J 2001; 20: 7085-7095.
35. Satoh J. Bioinformatics approach to identifying molecular biomarkers and networks in multiple sclerosis. Clin Exp Neuroimmunol 2010; 1: 127-140.